Literature DB >> 9163463

Prevalence of granulocytic Ehrlichia infection among white-tailed deer in Wisconsin.

E A Belongia1, K D Reed, P D Mitchell, C P Kolbert, D H Persing, J S Gill, J J Kazmierczak.   

Abstract

Human granulocytic ehrlichiosis (HGE) is caused by an agent that is nearly indistinguishable from the veterinary pathogens Ehrlichia equi and Ehrlichia phagocytophila. The deer tick, Ixodes scapularis, is a vector of the HGE agent, and the white-tailed deer is the primary host for adult Ixodes ticks. We assessed the distribution of granulocytic Ehrlichia infection among deer living within (Wisconsin) and outside (western and southern Iowa) the geographic range of L. scapularis. Whole-blood samples were tested for HGE 16S ribosomal DNA (rDNA) by PCR, and E. equi antibody was detected by indirect immunofluorescence assay (IFA). Antibody titers of > or = 1:64 were defined as positive, and all positive samples were retested with a second lot of substrate antigen. E. equi antibody was present in 14 (8%) of 187 Wisconsin deer and 0 of 60 Iowa specimens (rate ratio undefined; P = 0.025). An additional 30 serum samples from Wisconsin deer were excluded because IFA results were discrepant between substrate lots. The reciprocal antibody titers ranged from 64 to 512 (geometric mean, 141) for positive samples. PCR results were positive for 27 (15%) of 181 Wisconsin deer. The prevalence of infection in northwestern Wisconsin deer was not significantly different from that in central Wisconsin deer, as determined by IFA and PCR. In two samples that were sequenced, the 16S rDNA was nearly identical to that of the granulocytic Ehrlichia species but distinct from that of Anaplasma marginale. The DNA sequences of the samples differed from the published sequences for E. equi, E. phagocytophila, and the HGE agent by 1 or 2 nucleotides (> or = 99.1% homology) at phylogenetically informative sites. Granulocytic Ehrlichia organisms in deer are widely distributed within the geographic range of L. scapularis in Wisconsin. Deer may serve as useful sentinels for areas where HGE transmission to humans may occur.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163463      PMCID: PMC229768          DOI: 10.1128/jcm.35.6.1465-1468.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Studies on the infectious agent of tick-borne fever in sheep.

Authors:  A FOGGIE
Journal:  J Pathol Bacteriol       Date:  1951-01

2.  Equine ehrlichiosis.

Authors:  D H Gribble
Journal:  J Am Vet Med Assoc       Date:  1969-07-15       Impact factor: 1.936

3.  Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988.

Authors:  T R Eng; J R Harkess; D B Fishbein; J E Dawson; C N Greene; M A Redus; F T Satalowich
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

4.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

5.  Amblyomma americanum: a potential vector of human ehrlichiosis.

Authors:  B E Anderson; K G Sims; J G Olson; J E Childs; J F Piesman; C M Happ; G O Maupin; B J Johnson
Journal:  Am J Trop Med Hyg       Date:  1993-08       Impact factor: 2.345

6.  Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent).

Authors:  J E Barlough; J E Madigan; E DeRock; J S Dumler; J S Bakken
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

7.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

8.  Direct cultivation of the causative agent of human granulocytic ehrlichiosis.

Authors:  J L Goodman; C Nelson; B Vitale; J E Madigan; J S Dumler; T J Kurtti; U G Munderloh
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

9.  Transmission and passage in horses of the agent of human granulocytic ehrlichiosis.

Authors:  J E Madigan; P J Richter; R B Kimsey; J E Barlough; J S Bakken; J S Dumler
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

10.  Ixodes dammini as a potential vector of human granulocytic ehrlichiosis.

Authors:  P Pancholi; C P Kolbert; P D Mitchell; K D Reed; J S Dumler; J S Bakken; S R Telford; D H Persing
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  33 in total

1.  Contribution of polymorphisms in ankA, gltA, and groESL in defining genetic variants of Anaplasma phagocytophilum.

Authors:  Sanjay K Shukla; Vijay Aswani; Patrick J Stockwell; Kurt D Reed
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948

2.  Anaplasma phagocytophilum in central and western Wisconsin: a molecular survey.

Authors:  M Michalski; C Rosenfield; M Erickson; R Selle; K Bates; D Essar; R Massung
Journal:  Parasitol Res       Date:  2006-11       Impact factor: 2.289

3.  Detection of Ehrlichia canis in canine carrier blood and in individual experimentally infected ticks with a p30-based PCR assay.

Authors:  Roger W Stich; Yasuko Rikihisa; S A Ewing; Glen R Needham; Debra L Grover; Sathaporn Jittapalapong
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Molecular characterization of Anaplasma phagocytophilum and Borrelia burgdorferi in Ixodes scapularis ticks from Pennsylvania.

Authors:  Joshua W Courtney; Richard L Dryden; Jill Montgomery; Bradley S Schneider; Gary Smith; Robert F Massung
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  PCR detection and serological evidence of granulocytic ehrlichial infection in roe deer (Capreolus capreolus) and chamois (Rupicapra rupicapra).

Authors:  Jorge S Liz; John W Sumner; Kurt Pfister; Michel Brossard
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

6.  Experimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis.

Authors:  Cynthia M Tate; Daniel G Mead; M Page Luttrell; Elizabeth W Howerth; Vivien G Dugan; Ulrike G Munderloh; William R Davidson
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Prevalence of human-active and variant 1 strains of the tick-borne pathogen Anaplasma phagocytophilum in hosts and forests of eastern North America.

Authors:  Felicia Keesing; Diana J McHenry; Michelle Hersh; Michael Tibbetts; Jesse L Brunner; Mary Killilea; Kathleen LoGiudice; Kenneth A Schmidt; Richard S Ostfeld
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

8.  Isolation and propagation of the Ap-Variant 1 strain of Anaplasma phagocytophilum in a tick cell line.

Authors:  Robert F Massung; Michael L Levin; Ulrike G Munderloh; David J Silverman; Meghan J Lynch; Jariyanart K Gaywee; Timothy J Kurtti
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

9.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Seasonal dynamics of Anaplasma phagocytophila in a rodent-tick (Ixodes trianguliceps) system, United Kingdom.

Authors:  Kevin J Bown; Michael Begon; Malcolm Bennett; Zerai Woldehiwet; Nicholas H Ogden
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.